glp 1 receptor agonist contraindications Exploring the Side Effects of GLP-1 Agonist: To Ensure Its Optimal Positioning Glucagon-like peptide-1 receptor agonists and
Description
Gomes A, Souza D, Jos A, Chaves M, Victor J, Oliveira S, et al
doi: 10.1111/j.1467-789X.2011.00862.x
is the Principal Investigator of the ARISTOTELES project (Applying ARtificial Intelligence to define clinical trajectorieS for personalized predicTiOn and early deTEction of comorbidity and muLti-morbidity pattErnS) that received funding from the European Union within the Horizon 2020 research and innovation programme (grant no
in free solution, G002 had a stronger effect than G001
rate difference 0.13, 95% confidence interval 0.61 to 0.36 events per 10 000 person years)
